Mylan’s Biosimilars Close In On $1bn Milestone

Firm Reveals Annual Sales Total From Biosimilars Business

 
• By David Wallace
  
Billion_Dollar
Mylan’s cumulative sales of biosimilars are approaching $1bn in total • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products